Clarithromycin is a potent inhibitor of tumor-induced angiogenesis
- 1 July 1997
- journal article
- Published by Springer Nature in Zeitschrift für Die Gesamte Experimentelle Medizin
- Vol. 197 (4), 189-197
- https://doi.org/10.1007/s004330050068
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo.The Journal of Experimental Medicine, 1995
- Erythromycin Suppresses Interleukin 6 Expression by Human Bronchial Epithelial Cells: A Potential Mechanism of Its Anti-inflammatory ActionBiochemical and Biophysical Research Communications, 1995
- Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.The Journal of Experimental Medicine, 1994
- ClarithromycinDrugs, 1993
- Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.Journal of Clinical Investigation, 1993
- Modulation of acute morphine tolerance by corticotropin- releasing factor and dynorphin a in the mouse spinal cordLife Sciences, 1992
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature, 1992
- Inhibition of angiogenesis in vitro and in ovo with an inhibitor of cellular protein kinases, MDL 27032Journal of Cellular Physiology, 1992
- Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitroCell, 1989